Chemical activators of OFCC1 include a variety of compounds that can enhance its function through different biochemical pathways. Forskolin is known for its ability to directly activate adenylyl cyclase, which in turn increases the levels of cyclic AMP (cAMP) within the cell. The elevation of cAMP activates protein kinase A (PKA), a kinase that can phosphorylate OFCC1, leading to its activation. Similarly, Isoproterenol functions as a beta-adrenergic agonist, raising cAMP levels and subsequently activating PKA, which may then facilitate the phosphorylation and activation of OFCC1. Another cAMP analog, 8-Bromoadenosine 3',5'-cyclic monophosphate (8-Br-cAMP), also works by activating PKA, setting off a cascade that can result in the activation of OFCC1 through phosphorylation. Dibutyryl cyclic AMP (db-cAMP), being another cAMP analog, follows a similar activation route, diffusing into cells and initiating PKA-mediated phosphorylation of OFCC1.
Phorbol 12-myristate 13-acetate (PMA) and Ionomycin both activate protein kinase C (PKC) and calcium-dependent protein kinases, respectively, which can phosphorylate target proteins such as OFCC1, leading to its activation. The calcium ionophore A23187 similarly increases intracellular calcium, which may activate calcium-dependent protein kinases that phosphorylate and activate OFCC1. Epidermal Growth Factor (EGF) triggers the activation of its receptor and downstream kinases, which could include those that phosphorylate and activate OFCC1. Anisomycin, while inhibiting protein synthesis, uniquely activates stress-activated protein kinases (SAPKs), potentially leading to the phosphorylation and activation of OFCC1. This indicates the diverse cellular processes that can converge on the activation state of OFCC1. Calyculin A and Okadaic acid both serve as phosphatase inhibitors, preventing the dephosphorylation of proteins, which is a critical step in maintaining OFCC1 in an activated, phosphorylated state. By inhibiting the action of phosphatases, these compounds ensure that phosphorylated OFCC1 remains active. Lastly, Zinc chloride is often a cofactor for various enzymes and can stabilize the structure of certain proteins, including OFCC1, which can enhance its catalytic function. Through these various mechanisms, each chemical plays a role in influencing the activation state of OFCC1 through direct or indirect interactions with the protein and its associated signaling pathways.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Isoproterenol, a beta-adrenergic agonist, elevates intracellular cAMP, indirectly causing the activation of PKA which could phosphorylate and activate OFCC1. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C (PKC), which then phosphorylates target proteins including OFCC1. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin acts as a calcium ionophore, elevating intracellular calcium levels, which can activate calcium-dependent protein kinases that may phosphorylate and activate OFCC1. | ||||||
8-Bromo-cAMP | 76939-46-3 | sc-201564 sc-201564A | 10 mg 50 mg | $126.00 $328.00 | 30 | |
8-Br-cAMP is a cell-permeable cAMP analog that activates PKA, leading to phosphorylation and activation of OFCC1. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187 is a calcium ionophore that increases intracellular calcium, potentially activating calcium-dependent protein kinases that could phosphorylate and activate OFCC1. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
db-cAMP is a cAMP analog that can permeate cell membranes to activate PKA, which may lead to phosphorylation and subsequent activation of OFCC1. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin is a protein synthesis inhibitor that activates stress-activated protein kinases (SAPKs), which can lead to the activation of OFCC1 through phosphorylation. | ||||||
Calyculin A | 101932-71-2 | sc-24000 sc-24000A | 10 µg 100 µg | $163.00 $800.00 | 59 | |
Calyculin A is a phosphatase inhibitor that prevents dephosphorylation of proteins, thereby maintaining OFCC1 in an activated phosphorylated state. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Okadaic acid is another phosphatase inhibitor that leads to the accumulation of phosphorylated proteins, thus potentially maintaining OFCC1 in an activated state. | ||||||
Zinc | 7440-66-6 | sc-213177 | 100 g | $48.00 | ||
Zinc chloride can act as a cofactor for certain enzymes and may stabilize the structure of OFCC1, promoting its catalytic activity. | ||||||